Champions Oncology's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
Champions Oncology (NASDAQ:CSBR) is set to release its latest quarterly earnings report on July 24, 2023. Analysts estimate an earnings per share (EPS) of $-0.12. The company's past performance shows a trend of missing EPS estimates and subsequent drops in share price. The stock is currently trading at $6.9, down 18.19% over the last 52-week period.
July 21, 2023 | 5:02 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Champions Oncology is expected to report an EPS of $-0.12. Given the company's history of missing EPS estimates and the subsequent negative impact on the share price, investors may be cautious.
The company has a history of missing EPS estimates, which has typically resulted in a drop in share price. Given this trend and the current negative analyst estimate, the stock is likely to be negatively impacted in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100